{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:13:02Z","timestamp":1790745182571,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/tpj.2016.10","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T06:02:28Z","timestamp":1456812148000},"page":"170-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population"],"prefix":"10.1038","volume":"17","author":[{"given":"C-C","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-C","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-L","family":"Too","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-E","family":"Choon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-K","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-H","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-S","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"BFtpj201610_CR1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN . Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200\u20131205.","journal-title":"JAMA"},{"key":"BFtpj201610_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR study. J Invest Dermatol 2008; 128: 35\u201344.","journal-title":"J Invest Dermatol"},{"key":"BFtpj201610_CR3","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600\u20131607.","journal-title":"N Engl J Med"},{"key":"BFtpj201610_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","volume":"50","author":"CC Chang","year":"2011","unstructured":"Chang CC, Too CL, Murad S, Hussein SH . Association of HLA-B*15:02 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol 2011; 50: 221\u2013224.","journal-title":"Int J Dermatol"},{"key":"BFtpj201610_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1365-4632.2010.04481.x","volume":"49","author":"WY Ding","year":"2010","unstructured":"Ding WY, Lee CK, Choon SE . Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol 2010; 49: 834\u2013841.","journal-title":"Int J Dermatol"},{"key":"BFtpj201610_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1046\/j.1365-4362.1998.00490.x","volume":"37","author":"MD Kamaliah","year":"1998","unstructured":"Kamaliah MD, Zainal D, Mokhtar N, Nazmi N . Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia. Int J Dermatol 1998; 37: 520\u2013523.","journal-title":"Int J Dermatol"},{"key":"BFtpj201610_CR7","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","volume":"353","author":"B Rzany","year":"1999","unstructured":"Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R . Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet 1999; 353: 2190\u20132194.","journal-title":"Lancet"},{"key":"BFtpj201610_CR8","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/epi.12217","volume":"54","author":"YK Cheung","year":"2013","unstructured":"Cheung YK, Cheng SH, Chan EJ, Lo SV, Ng MH, Kwan P . HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia 2013; 54: 1307\u20131314.","journal-title":"Epilepsia"},{"key":"BFtpj201610_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1533-2500.2011.00479.x","volume":"12","author":"K Kulkantrakorn","year":"2012","unstructured":"Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S et al. HLA-B*15:02 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. Pain Pract 2012; 12: 202\u2013208.","journal-title":"Pain Pract"},{"key":"BFtpj201610_CR10","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","volume":"49","author":"C Locharernkul","year":"2008","unstructured":"Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*15:02 allele in Thai population. Epilepsia 2008; 49: 2087\u20132091.","journal-title":"Epilepsia"},{"key":"BFtpj201610_CR11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","volume":"48","author":"CB Man","year":"2007","unstructured":"Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS et al. Association between HLA-B*15:02 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007; 48: 1015\u20131018.","journal-title":"Epilepsia"},{"key":"BFtpj201610_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4103\/0378-6323.57718","volume":"75","author":"TY Mehta","year":"2009","unstructured":"Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB et al. Association of HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 2009; 75: 579\u2013582.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"BFtpj201610_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","volume":"51","author":"W Tassaneeyakul","year":"2010","unstructured":"Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH et al. Association between HLA-B*15:02 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 2010; 51: 926\u2013930.","journal-title":"Epilepsia"},{"key":"BFtpj201610_CR14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","volume":"20","author":"Q Wang","year":"2011","unstructured":"Wang Q, Zhou JQ, Zhou LM, Chen ZY, Fang ZY, Chen SD et al. Association between HLA-B*15:02 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland. Seizure 2011; 20: 446\u2013448.","journal-title":"Seizure"},{"key":"BFtpj201610_CR15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","volume":"97","author":"SH Kim","year":"2011","unstructured":"Kim SH, Lee KW, Song WJ, Jee YK, Lee SM, Kang HR et al. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res 2011; 97: 190\u2013197.","journal-title":"Epilepsy Res"},{"key":"BFtpj201610_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","volume":"364","author":"M McCormack","year":"2011","unstructured":"McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperaviciute D, Carrington M et al. HLA-A*31:01 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011; 364: 1134\u20131143.","journal-title":"N Engl J Med"},{"key":"BFtpj201610_CR17","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","volume":"20","author":"T Ozeki","year":"2011","unstructured":"Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y et al. Genome-wide association study identifies HLA-A*31:01 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 2011; 20: 1034\u20131041.","journal-title":"Hum Mol Genet"},{"key":"BFtpj201610_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2217\/pgs.09.162","volume":"11","author":"SI Hung","year":"2010","unstructured":"Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 2010; 11: 349\u2013356.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201610_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","volume":"209","author":"JC Roujeau","year":"2005","unstructured":"Roujeau JC . Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123\u2013129.","journal-title":"Toxicology"},{"key":"BFtpj201610_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609\u2013611.","journal-title":"Br J Dermatol"},{"key":"BFtpj201610_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther 2010; 88: 60\u201368.","journal-title":"Clin Pharmacol Ther"},{"key":"BFtpj201610_CR22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"SH Kardaun","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013; 169: 1071\u20131080.","journal-title":"Br J Dermatol"},{"key":"BFtpj201610_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","volume":"20","author":"JB Haldane","year":"1956","unstructured":"Haldane JB . The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956; 20: 309\u2013311.","journal-title":"Ann Hum Genet"},{"key":"BFtpj201610_CR24","doi-asserted-by":"publisher","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","volume":"39","author":"FF Gonzalez-Galarza","year":"2011","unstructured":"Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR . Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: D913\u2013D919.","journal-title":"Nucleic Acids Res"},{"key":"BFtpj201610_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1399-0039.2009.01281.x","volume":"74","author":"C Kongmaroeng","year":"2009","unstructured":"Kongmaroeng C, Romphruk A, Ruangwerayut R, Paupairoj C, Leelayuwat C, Inoko H . HLA-B*15 subtypes in Burmese population by sequence-based typing. Tissue Antigens 2009; 74: 164\u2013167.","journal-title":"Tissue Antigens"},{"key":"BFtpj201610_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.","journal-title":"Nature"},{"key":"BFtpj201610_CR27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1084\/jem.181.3.1133","volume":"181","author":"JE Gumperz","year":"1995","unstructured":"Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P . The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995; 181: 1133\u20131144.","journal-title":"J Exp Med"},{"key":"BFtpj201610_CR28","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.jaci.2011.12.990","volume":"129","author":"CY Wei","year":"2012","unstructured":"Wei CY, Chung WH, Huang HW, Chen YT, Hung SI . Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol 2012; 129: e5.","journal-title":"J Allergy Clin Immunol"},{"key":"BFtpj201610_CR29","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jaci.2011.08.013","volume":"128","author":"TM Ko","year":"2011","unstructured":"Ko TM, Chung WH, Wei CY, Shih HY, Chen JK, Lin CH et al. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. J Allergy Clin Immunol 2011; 128: e11.","journal-title":"J Allergy Clin Immunol"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201610","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T07:16:53Z","timestamp":1647933413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFtpj201610"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2016.10","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,1]]},"assertion":[{"value":"8 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}